MSB 0.36% $1.38 mesoblast limited

Ann: 36-Month Results of Phase 3 Trial in Chronic Low Back Pain, page-94

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 35,472 Posts.
    lightbulb Created with Sketch. 2863
    "We are treating patients in the Phase 3 trial with back pain so advanced their only real alternative choice is interventional surgery like spinal fusion."

    Prove this statement
    as if this is the case, tell me about the placebo results
    I think you are exaggerating here big time for effect....as Mesoblast themselves have stated in presentation and announcement the biggest effect came from early stage intervention from DDD.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.